Product Information
NITROFURANTOIN MONO-MCR 100 MG is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.2958 per EA under NDC 59746076201. Its NADAC has been published 191 times since Feb 8, 2023.
FDA first approved this application on Feb 18, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 75 mg/1; mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746076201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROFURANTOIN; NITROFURANTOIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211013FDA Approved
2/18/2022
TE Code
AB
On Market Since
2/22/2022
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN MONO-MCR 100 MG has been published 191 times since Feb 8, 2023, and over the history we have for it it has declined 29.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2958 per EA |
|---|---|
| All-time high | $0.5568 (Jan 10, 2024) |
| All-time low | $0.2561 (Nov 20, 2024) |
| 52-week high | $0.3519 |
| 52-week low | $0.2958 |
| Median price | $0.3510 |
| Average price | $0.3888 |
| Largest weekly change | +28.5% (Jun 19, 2024) |
| Weeks tracked | 191 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Jubilant Cadista Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nitrofurantoin (monohydrate/macrocrystals) market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN MONO-MCR 100 MG?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MONO-MCR 100 MG, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.2958 per EA (NDC 59746076201), effective Sep 30, 2026.
How has the price of NITROFURANTOIN MONO-MCR 100 MG changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has declined 29.3%. It has been tracked across 191 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MONO-MCR 100 MG?
Since Feb 8, 2023, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has ranged from a low of $0.2561 (Nov 20, 2024) to a high of $0.5568 (Jan 10, 2024), with a median of $0.3510 per EA.
Are there cheaper alternatives to NITROFURANTOIN MONO-MCR 100 MG?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NITROFURANTOIN MONO-MCR 100 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures NITROFURANTOIN MONO-MCR 100 MG?
NITROFURANTOIN MONO-MCR 100 MG (NDC 59746076201) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.